GC Genome Corporation (KOSDAQ:340450)
8,000.00
+380.00 (4.99%)
Nov 18, 2026, 3:30 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 189.21 billion as of November 17, 2026. It is the 22,575th most valuable company in the world and the 818th biggest in South Korea. Its market cap has increased by 16.96% in one year.
Market Cap
189.21B
Enterprise Value
150.93B
Revenue
32.64B
Global Rank
Country Rank
#818 South Korea
PE Ratio
34.81
ChartMarket Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 189.21B, a decrease of -27.93%. That is a compound annual growth rate of -20.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 189.21B | 17.30% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDIPOST | 310.73B |
| Orum Therapeutics | 288.88B |
| SillaJen | 263.81B |
| Genomictree | 206.18B |
| Bioneer | 157.70B |
| Helixmith | 150.80B |
| GC Cell | 147.72B |
| NeoImmuneTech | 145.63B |